16 articles for SY Hwang
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
6
Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2.

University of Michigan
12
Rational design of selective thrombin inhibitors

TBA
4
Discovery of PPARγ and glucocorticoid receptor dual agonists to promote the adiponectin and leptin biosynthesis in human bone marrow mesenchymal stem cells.

Seoul National University
6
Prenylated Chrysin Derivatives as Partial PPARγ Agonists with Adiponectin Secretion-Inducing Activity.

Seoul National University
4
Galangin 3-benzyl-5-methylether derivatives function as an adiponectin synthesis-promoting peroxisome proliferator-activated receptor γ partial agonist.

Seoul National University
1
Discovery of a 2,4-diphenyl-5,6-dihydrobenzo(h)quinolin-8-amine derivative as a novel DNA intercalating topoisomerase IIα poison.

Yeungnam University
45
Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists.

Daegu-Gyeongbuk Medical Innovation Foundation
7
2-Phenyl-8-(1-phenylallyl)-chromenone compounds have a pan-PPAR modulator pharmacophore.

Seoul National University
11
Fluorobenzamidrazone thrombin inhibitors: influence of fluorine on enhancing oral absorption.

Biotech Research Institute
19
Thrombin inhibitors based on a propargylglycine template.

Biotech Research Institute
7
Potent and efficacious thienylamidine-incorporated thrombin inhibitors.

Biotech Research Institute
10
Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor.

Biotech Research Institute
55
MAPK inhibitors

Everbrilliant Pharma
69
Intermediate compound of novel tetrahydronaphthyl urea derivative

Mochida Pharmaceutical
55
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.

Parke-Davis Pharmaceutical Research